LivaNova PLC

LivaNova PLC

LIVN

$93.40

Updated: 04/11/2026, 15:35:07

Market Cap
$5.13B
Sector
Healthcare
Industry
Medical - Devices
Country
GB

No historical data available

Company Profile

LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.

USD
NASDAQ
CEO: Vladimir A. Makatsaria
Employees: 3,300
https://www.livanova.com
Asset Summaries
Latest generated summaries for LIVN

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for LIVN.
Share price
$93.40
Market cap
$5.13B
Exchange
NASDAQ
Currency
USD
CEO
Vladimir A. Makatsaria
Employees
3,300
IPO date
19/10/2015
Beta
0.912
Last dividend
$0.00
Day range
$89.50 – $94.22
52-week range
$48.82 – $94.22
1-day performance
16.90%
1-year performance
91.32%
Current drawdown (1Y)
-0.87%
CIK
0001639691
CUSIP
G5509L101
ISIN
GB00BYMT0J19
Created
07/12/2025, 05:04:09
Last update
04/11/2026, 15:35:07

Track LivaNova PLC with an AI analyst

See which prediction-market events move LIVN, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.